COSELA (trilaciclib) — NDC 73462-101 by G1 Therapeutics, Inc.
COSELA (trilaciclib) — NDC 73462-101 by G1 Therapeutics, Inc. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: COSELA; Generic name: trilaciclib; Product NDC: 73462-101.
| Brand name | COSELA |
|---|---|
| Generic name | trilaciclib |
| Product NDC | 73462-101 |
| Labeler | G1 Therapeutics, Inc. |
| Dosage form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active ingredients | TRILACICLIB DIHYDROCHLORIDE 300 mg/20mL |
| Pharmacologic class | Cyclin-dependent Kinase 4 Inhibitors [MoA], Cyclin-dependent Kinase 6 Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrus |
| Marketing category | NDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →